Y'know what really shits me about our PR....apart from the fact I have to send them reminders that I've asked em questions...
I asked them a question about our LANI trial, particulately who (us or BARDA or FDA?) is driving the 40mg vs 80 mg dosage. They gave me some horseshit about this being normal procedure in dose ranging but I brought to her attention that 40mg is the max dosage that is being retailed in Japan...doesn't that mean we have already arrived at our optimum dosage?
Don't get me wrong, I'm happy they are testing higher dosages to push the envelope but I assume we've had to do this additional Ph I trial to accommodate the higher dosage...and I assume they are waiting for those results before our overdue Ph II can start...
What happens if there is a SNAFU safety event in that Ph I trial, does that mean we can't test 80mg in Ph II?
Add to My Watchlist
What is My Watchlist?